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outcome can still be made. Further research work in this 
area will allow us to target these approaches more accu-
rately to those patients who can benefit most.
Keywords Polytrauma · Damage control surgery · Severe 
haemorrhage · Resuscitation
Introduction
The term “damage control” originates in naval conflict, being 
used to describe an approach to managing damaged warships 
that aims to maintain seaworthiness and operational status 
rather than repair all damage [1, 2]. The concept has been 
transferred into medical practice and used to describe a man-
agement approach in severely and multiply injured patients. 
This is relevant to the widely popularised two hit model of 
the systemic inflammatory response to trauma which hypoth-
esises that serious injury may lead to excessive activation of 
the immune-inflammatory system (the first hit). Whilst in 
this state, which is time dependent, further insult (the sec-
ond hit), including surgical intervention, can tip the balance 
pushing patients into a state of uncontrolled physiological 
disequilibrium (termed the systemic inflammatory response 
syndrome). The initial pathophysiologic response to severe 
injury is characterised by the classically described lethal triad 
of hypothermia, coagulopathy and acidosis. These features 
together form a progressive cycle with resultant exacerbation 
of haemorrhage driving the patients physiology further from 
normal. This situation is often rapidly fatal unless corrected. 
Even when the patient survives the initial phase, the result is 
frequently multiple organ dysfunction and damage including 
acute lung injury, renal and hepatic dysfunction, circulatory 
and immune failure. Such a situation is a potent cause of late 
morbidity and mortality in multiply injured patients.
Abstract 
Background Damage control resuscitation describes an 
approach to the early care of very seriously injured patients. 
The aim is to keep the patient alive whilst avoiding interven-
tions and situations that risk worsening their situation by driv-
ing the lethal triad of hypothermia, coagulopathy and acidosis 
or excessively stimulating the immune-inflammatory sys-
tem. It is critical that the concepts and practicalities of this 
approach are understood by all those involved in the early 
management of trauma patients. This review aims to summa-
rise this and discusses current knowledge on the subject.
Interventions Damage control resuscitation forms part 
of an overall approach to patient care rather than a specific 
intervention and has evolved from damage control surgery. 
It is characterised by early blood product administration, 
haemorrhage arrest and restoration of blood volume aim-
ing to rapidly restore physiologic stability. The infusion 
of large volumes of crystalloid is no longer appropriate, 
instead the aim is to replace lost blood and avoid dilution 
and coagulopathy. In specific situations, permissive hypo-
tension may also be of benefit, particularly in patients with 
severe haemorrhage from an arterial source. As rapid arrest 
of haemorrhage is so important, team-based protocols 
that deliver patients rapidly but safely, via CT scan where 
appropriate, to operating theatres or interventional radiol-
ogy suites form a critical part of this process.
Conclusions Given that interventions are so time depend-
ent in the severely injured, it is likely that by further 
improving trauma systems and protocols, improvements in 
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Damage control surgery aims to reduce this effect by 
minimising the early surgical burden and therefore the sec-
ond hit. The patient is then taken to critical care facilities for 
ongoing resuscitation and physiologic restoration. Once the 
initial phase has passed, staged anatomic reconstruction is 
undertaken to restore long term function. The intention is to 
avoid excessive surgical stress from lengthy or specifically 
stimulatory reconstructive interventions in patients who are 
physiologically not equipped to withstand them. Instead the 
focus is changed to undertake only interventions required to 
save life and limb and then stabilise the patients’ physiology, 
delaying definitive reconstruction until recovery has begun.
Damage control surgery was first developed in the man-
agement of abdominal injuries, particularly after gun shot 
wounds. This was defined as the ‘initial control of haemor-
rhage and contamination followed by intraperitoneal pack-
ing and rapid closure’ to allow for ‘resuscitation to normal 
physiology in the intensive care unit and a subsequent 
definitive re-exploration’ [3]. Subsequently this rationale 
was also applied to skeletal trauma (damage control ortho-
paedics, DCO). In this context the focus is on temporary 
skeletal stabilization, usually by external fixation, and man-
agement of soft tissue injury with definitive reconstruction 
once the patients physiology allows [1, 4–6].
It is recognised that stresses other than surgery can also 
contribute to this process of disordered immune activation, 
including episodes of hypotension, hypoxia and relative tis-
sue ischaemia as well as early complications such as infec-
tion [7, 8]. Thus, it can be seen that this treatment rationale 
should be applied holistically to the patient if its benefits 
are to be realised. Recently therefore, greater attention has 
been given to the resuscitative phase of management in mul-
tiply injured patients. Clinical understanding has expanded 
greatly from modern military conflict, these advances are 
now being transferred to civilian practice. The development 
of regional and national trauma systems with resultant con-
centration of severely injured patients has further increased 
experience. Ongoing basic science and clinical research has 
lead to an increasing understanding of these processes at a 
molecular level. Damage control resuscitation represents 
evidence based evolution of different resuscitation protocols 
that have been developed over many years [1, 2].
This paper aims to review current practice in the resus-
citation of multiply and severely injured patients and docu-
ment lessons leaned thus far when this approach is used.
Pathophysiology
Hypothermia
Hypothermia is common among polytrauma patients, espe-
cially those with haemorrhagic shock. The causes are multiple 
but include physical exposure to the environment both at the 
scene and in hospital, intoxication, circulatory changes and 
administration of cold fluids [9]. The situation may be exacer-
bated by loss of thermoregulatory control due to uncoupling 
of normal metabolic pathways, resulting in the loss of home-
othermic ability as physiologic derangement ensues.
Severe hypothermia is associated with a high mortal-
ity. Prognosis is directly related to the degree of hypo-
thermia, with 100 % mortality having been observed in 
patients who present with core body temperatures under 
32.8° [2]. Hypothermia causes and exacerbates bleeding 
abnormalities through multiple mechanisms. Moderate 
hypothermia (32–34 °C), directly reduces coagulation fac-
tor activity by approximately 10 % for each degree fall in 
temperature, whilst also inhibiting platelet aggregation [9, 
10]. Decreased thromboxane activity potentiates bleeding, 
which is aggravated by dysregulation of coagulation fac-
tors and enzymes [11]. Steps should therefore be taken at 
every stage to prevent hypothermia and consideration given 
to rewarming those in which this has already occurred, this 
is discussed later in the review [2].
Coagulopathy
Acute traumatic coagulopathy is a process recognised to 
occur early following the tissue trauma and shock result-
ing from severe injury. In polytrauma patients it has been 
associated with increased bleeding morbidity, higher trans-
fusion requirements, increased risk of organ dysfunction, 
longer critical care stays and increased overall mortality 
[12–14]. The severity of post traumatic coagulopathy has 
been shown to directly correlate with overall injury sever-
ity [15]. Once established this state is extremely difficult to 
correct and is a potent cause of early death in such patients.
Historically, it was thought that coagulopathy in the pol-
ytrauma patient was due mainly to fluid administration and 
hypothermia, management was somewhat neglected [16, 
17]. Administration of clotting products was only initiated 
once coagulopathy had ensued or large volumes of blood 
had been given, usually in excess of 10 units of red blood 
cells within 24 h. Large volumes of crystalloid solution 
were generally administered alongside packed red blood 
cells. It was recognised that this approach exacerbated 
coagulopathy and frequently lead to unsalvagable situa-
tions by further driving the lethal triad to exhaustion [15].
Coagulopathy of trauma arises from decreased circulating 
concentration, and dysfunction of, various components of the 
clotting mechanism. The incidence of coagulopathy appears to 
correlate directly with the volume of clear fluid administered 
supporting the view that dilution is contributory [18]. The abil-
ity to rapidly analyse different aspects of the clotting cascade 
has increased understanding of individual component dys-
function in this process. Hypovolaemic shock, reduced protein 
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C levels and protein C activation have been observed in acute 
trauma [12]. This appears to result from the combined influ-
ence of acidosis, hemodilution and hypothermia [12]. Despite 
a paucity of research in this area it does appear that the coag-
ulaopathy seen in acute trauma is driven by the activation of 
protein C and is associated with the depletion of many clotting 
factors including: I, II, V, VII, VIII, IX and X [14].
Two types of coagulopathy have been described; systemi-
cally acquired coagulopathy (SAC) and endogenous acute 
coagulaopathy (EAC). SAC is itself associated with the 
lethal triad of acidosis, hemodilution and hypothermia. EAC 
has been described as a precursor to SAC in the polytrauma 
patient with a coagulopathy related to the activation of the pro-
tein C pathway. In the presence of EAC mortality rates four 
times higher than in those with normal coagulation have been 
observed, along with increased transfusion requirements and 
rates of multiple organ dysfunction. The processes underlying 
these coagulopathic states are not fully understood and hence 
there are currently no firm definitions describing them [12].
Acidosis
Inadequate or inappropriate circulation in trauma patients 
results from blood loss, tissue damage and vascular injury. This 
results in the generation of toxic metabolites, anaerobic metab-
olism and lactic acidosis. Homeostatic mechanisms carefully 
maintain a narrow pH range and as the patient deteriorates may 
become impaired themselves, exacerbating such problems. The 
degree of acidosis and lactate levels on admission have been 
shown to predict mortality in the trauma patient [11].
Alterations in pH will detrimentally affect enzymatic 
function throughout the body, resulting in multiple tissue and 
therefore organ dysfunction. Perhaps most importantly in the 
bleeding patient, the severity of acidosis has been shown to 
correlate with the dysfunction of coagulation factors [11]. A 
fall in pH from 7.4 to 7.0 reduces factor VIIa’s activity by 
90 %, whilst the activity of factors Xa/Va have been shown 
to decrease by 70 % [2, 11]. Thus it can be seen that coag-
ulopathic bleeding will worsen the state of shock, decreas-
ing tissue perfusion and exacerbating acidosis and therefore 
coagulopathy. To address this, it is important to optimise 
oxygen delivery through blood transfusions and by augment-
ing cardiac output pharmacologically, whilst attempts are 
made to arrest haemorrhage as soon as possible [19]. This is 
especially evident at pH levels of 7.2 or less which have been 
associated with decreased cardiac contractility and cardiac 
output, vasodilation, hypotension, and bradycardias [2].
Damage control resuscitation
Damage control resuscitation (DCR) forms part of an 
overall approach to patient care rather than a specific 
intervention and has evolved from damage control surgery. 
It is characterised by early blood product administration 
and haemorrhage control with restoration of blood vol-
ume and physiologic stability [1]. This approach should be 
initiated at first contact with the patient in the prehospital 
environment and continue through their initial reception 
and treatment until haemorrhage is arrested and physiology 
corrected. Recognition of patients at high risk is therefore 
critical. It has repeatedly been shown that early intervention 
to prevent physiologic derangement is far more effective 
than trying to correct self amplifying processes once they 
are established. Such an approach is most effective when 
delivered as part of entire package of care along with rapid 
surgery aimed at life and/or limb salvage whilst avoiding 
time consuming and potentially traumatic reconstruction. 
As rapid arrest of haemorrhage is so important, team based 
protocols that deliver patients rapidly but safely, via CT 
scan where appropriate, to operating theatres or interven-
tional radiology suites form a critical part of this process. 
The main drive behind all of this is to try and avoid pre-
cipitating further pathophysiologic responses or amplifying 
those already underway [1, 20]. Guidelines for the use of 
DCR have now been implemented in many units and form 
the basis of early patient management protocols in major 
trauma centres [15].
Indications for damage control
As DCR aims to pre-emptively address occult physiologic 
derangement to prevent catastrophic deterioration, early 
recognition of patients at risk is tantamount [2]. In the 
context of acute major trauma, all patients should initially 
be managed by a DCR approach. Such situations remain 
highly individual and dynamic, it is not sensible to con-
struct strict criteria based protocols. It is quite reasonable to 
switch from one rationale to the other, responding to dete-
rioration or improvement, though it is important to note the 
overall trend over time and adopt a damage control ration-
ale where doubt exists [15]. Indeed it has been suggested 
that more widespread use of DCR might mean that damage 
control surgery may be required less often, as the patient is 
prevented from entering a pathophysiologic state in the first 
place.
A DCR approach should therefore be considered in all 
patients whose injuries place them at risk of significant 
haemorrhage or physiologic derangement. This would 
include those with or suspected of having major abdomi-
nal or thoracic visceral injury, significant pelvic trauma, 
significant amputation, multiple long bone fractures and 
head injuries. This should be escalated where patient physi-
ology and biochemistry indicates that major blood loss is 
occurring or a pathophysiologic response is underway. The 
tables below suggest potential indicators of these events.
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Damage control surgery
The Hanover group have developed of a set of sensible 
guidelines to aid decision making in these complex cases 
(Figs. 1, 2) [6]. This divides patients into four groups, 
those in extremis (peri-arrest with end stage signs of 
shock), haemodynamically unstable patients, borderline 
patients and stable patients. It is suggested that those in 
Fig. 1  Defining borderline 
patients and factors associated 
with poor outcome in trauma 
patients—ISS injury severity 
score, AIS abbreviated injury 
scale, ICP intracranial pressure, 
PAWP pulmonary artery wedge 
pressure
Fig. 2  Diagram illustrating the 
concept of prioritisation and 
decision making in severely 
injured patients—OR operating 
room, ICU intensive care unit—
reproduced with kind permis-
sion of author [21]
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extremis and unstable patients are managed throughout 
utilising a damage control approach. Stable patients can 
be managed using standard protocols, the more difficult 
group are the borderline patients. These exhibit injury 
patterns or physiologic responses that are associated with 
poor outcome but have not been haemodynamically unsta-
ble or have responded to intervention and become stable. It 
is suggested that a flexible approach is adopted, with such 
patients being initially managed using standard protocols 
and having definitive reconstruction of injuries requiring 
surgery. Should such injury patterns be seen in conjunc-
tion with physiologic derangement consideration should 
be given to adopting a surgical damage control approach 
from the outset. Similarly, should there be any indica-
tion of physiologic deterioration at any point the treat-
ment rationale should switch to damage control. It would 
therefore seem sensible to adopt a DCR approach in bor-
derline patients until they have proven themselves stable 
and physiologically resilient [19, 21–23]. This is detailed 
in Fig. 1. 
Damage control resuscitation [1, 8, 9, 15, 24, 25]
Specific indications have more recently been described to 
indicate a damage control approach to resuscitation from 
the outset. These are summarised in Fig. 3 and describe a 
series of injury patterns, physiological parameters and lab 
results that suggest a patient might be at risk. They are par-
ticularly worrisome if seen in combination. Care must be 
taken in those with head injury when considering permis-
sive hypotension. This will detrimentally affect cerebral per-
fusion pressure and should be avoided, it is discussed below.
Key components of damage control resuscitation
DCR in trauma differs from traditional approaches by 
attempting an earlier and more aggressive correction of 
coagulopathy and metabolic derangements and prioritising 
haemorrhage control.
The main components of DCR include [1, 26]:




•	 Correction of acidosis
•	 Arrest of haemorrhage by surgical and non-surgical 
techniques.
Each of these is examined below. It is reasonable to 
apply individual aspects of this approach initially and esca-
late or step back as more information regarding injuries 
and response becomes apparent. For example, in a multiply 
injured patient with suspected abdominal and pelvic injury, 
but without initial indicators of massive blood loss, it is 
reasonable to rewarm the patient as required whilst adopt-
ing restrictive fluid resuscitation until more information 
is available. It should be ensured that blood products are 
available should they be required. Any deterioration should 
prompt the use of a Haemostatic resuscitation regime 
potentially with permissive hypotension whilst arrange-
ments are made for surgical or endovascular haemorrhage 
arrest.
Permissive hypotension and restrictive fluid administration
Traditional fluid resuscitation in the polytrauma patient 
involved rapid infusion of large volumes of clear fluids in 
an attempt to rapidly restore circulating blood volume and 
blood pressure. It has become apparent that this approach 
has several potentially detrimental consequences. The 
premise of permissive hypotension is to keep the blood 
pressure low enough to avoid exacerbating haemorrhage 
by hydrostatic clot disruption whilst maintaining adequate 
end organ perfusion. Permissive hypotension and restrictive 
fluid administration are therefore reciprocal components 
of this approach; initial fluid administration is delayed 
or minimised and less aggressive resuscitative end points 
Fig. 3  Indications for damage control resuscitation
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are used. In practical terms this means targeting systolic 
blood pressures of 70–90 or 50 mmHg mean arterial. This 
approximately equates to aiming for the restoration of a 
palpable radial pulse [2, 11]. Such an approach decreases 
both the severity and incidence of dilutional coagulopathy, 
and as such compliments a strategy of haemostatic resusci-
tation [11]. Second, this reduces fluctuations in, and eleva-
tion of, systolic blood pressure which may disrupt the pre-
mature blood clot forming in areas of injury causing further 
bleeding.
The concept of delayed fluid administration in trauma 
is not new. In the early 1990s a randomised controlled 
trial of immediate (pre-hospital) versus delayed fluid 
administration in patients with penetrating truncal injuries 
demonstrated decreased morbidity (including systemic 
inflammatory response syndrome, pulmonary oedema and 
thrombocytopaenia) and mortality in the delayed resus-
citation group as well as a shorter hospital stay [27]. The 
delayed administration group, who received no IV fluid 
prior to entering the operating room, had lower recorded 
blood pressures pre-hospital and in the emergency room. 
Further analysis of this data showed that such an approach 
might only be advantageous in those with specific injuries, 
particularly penetrating cardiac trauma, this subgroup ben-
efited most from delayed fluid resuscitation. This study 
stimulated changes to resuscitative protocols, with con-
sideration given to the timing of fluid administration and 
resuscitative end points [2, 11].
Whilst having theoretical and practical merits, clear 
evidence to support permissive hypotension has not been 
entirely forthcoming. Animal studies appear to support this 
approach in models of simple exsanguinating haemorrhage 
and clinical work in other situations, particularly ruptured 
aortic aneurysm, has demonstrated advantages. Whilst this 
situation is likely analogous to simple vascular or visceral 
injury, the situation in trauma is often more complex, par-
ticularly in patients with head injury and multiple blunt 
trauma. In the head injured, the competing interests of main-
taining cerebral perfusion pressure whilst keeping the patient 
from exsanguination can be extremely challenging, hypoten-
sion in such patients is generally poorly tolerated. Current 
advice is to avoid this approach in head injured patients. Fur-
ther work is necessary to clearly delineate in what situations 
permissive hypotension should be rigorously applied but as 
with much of DCR decision making should be individual-
ised [11, 28, 29]. New technologies are allowing novel end 
points in resuscitation to be investigated which may prove 
more appropriate than blood pressure in the severely injured. 
These include near-infrared spectroscopy, measurement 
of skeletal muscle acid–base status and more sophisticated 
measures of global acid–base balance [7].
In conclusion therefore, it would appear that restricting 
initial IV fluid administration in the severely injured should 
have advantages and the infusion of large volumes of crys-
talloid is no longer appropriate. In specific situations, per-
missive hypotension may also be of benefit, particularly in 
patients with severe haemorrhage from an arterial source. 
Great caution should be taken in those with concomitant 
head injury and further work is required to clearly delineate 
which patients might benefit the most from this approach 
[11].
Haemostatic resuscitation and massive transfusion 
protocols
Better understanding of the mechanisms underlying coag-
ulopathy in trauma has lead to a paradigm shift in man-
agement. Recent protocols attempt to prevent such states 
occurring in the first place or correct them very rapidly. 
In terms of restoring circulating volume alone, the type of 
fluid administered appears to have little consequence. Some 
advantages to the use of hypertonic saline exist in patients 
with traumatic brain injury [11, 30, 31]. In general how-
ever, there are good reasons to avoid clear fluids and early 
administration of blood and blood products is generally 
recommended to replace all the constituents of whole blood 
from the outset. Recent evidence suggests that timely trans-
fusion, can reduce blood product use overall [7, 32]. The 
concept centres around the assumption that coagulopathy is 
present very early after severe injury and rapidly corrective 
interventions can improve outcomes [2, 33]. This requires 
us to rethink our concept of massive transfusion and mas-
sive transfusion protocols. Massive transfusion has tradi-
tionally been defined as those patients requiring more than 
10 units of red cells in 24 h. Management of coagulopathy 
was almost exclusively reactive and only instituted once 
the patient had received large volumes of blood. Clearly 
a DCR approach requires the recognition of patients with 
the potential to require large volume transfusion, this is dis-
cussed above [11, 34].
Local protocols will vary but Haemostatic resuscitation 
aims to deliver a mixture of red blood cells (RBCs), fresh 
frozen plasma (FFP) and platelets in approximately a 1:1:1 
ratio [1]. This is known as balanced transfusion, adminis-
tration of packed red blood cells being balanced with coag-
ulation factor delivery. Without this, dilution of coagula-
tion factors will exacerbate consumptive loss, this has the 
potential to rapidly result in a spiral of coagulopathy and 
worsening blood loss [11]. Whilst such protocols have been 
found to reduce morbidity and mortality, [35] the require-
ment for such large amounts of clotting products and the 
exact composition of this transfusion regime does remain 
controversial [36]. An observational study recently dem-
onstrated the early survival benefits of delivering clotting 
product to red cell ratios above 0.5:1 in patients with severe 
haemorrhage [37]. Conversely, recent military evidence 
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suggests that ratios of a low as 0.35:1 may be preferable 
[38]. Clearly further work is needed to clarify the situation 
and it may be that patients with different injury patterns 
benefit from different regimes. Most major trauma centres 
have developed their own protocols based upon availability 
of blood products and local experience [11].
The documented detrimental effects of red blood cell 
transfusion should also be considered in this context. 
Blood transfusion has been shown to induce derangements 
in the immune-inflammatory system with both systemic 
pro-inflammatory effects and increased infection reported. 
Volume of blood transfused has been demonstrated to be 
an independent risk factor for overall morbidity and mor-
tality in trauma patients. Degradation of stored red blood 
cells during storage has been implicated with decreased 
red blood cell aggregation and increased release of inflam-
matory mediators [9]. Further concern comes from the 
aggressive use of blood products in cases that initially 
appear to warrant a DCR approach but are subsequently 
found to be less severely injured than was thought. These 
patients may receive blood and blood products that were 
not required at all. The effect of these small volume trans-
fusions is less clear and needs further investigation if the 
consequences of unnecessary use of blood products are to 
be understood [39]. Currently therefore, a careful balance 
must be struck to avoid over zealous use of blood prod-
ucts. Recent evidence would suggest that massive trans-
fusion is still associated with poor outcome and overall 
use of red blood cells has decreased over time, whilst that 
of clotting products has increased. This has been associ-
ated with a fall in overall mortality [40]. It is important 
to consider that other factors might explain the observed 
improvements in outcome.
Advances in laboratory methods mean that when 
patients do suffer derangement to their clotting mecha-
nism this can now be assessed more rapidly and accu-
rately. Thromboelastography (TEG) provides users with 
a holistic overview of coagulation through the analysis 
of platelet function, clotting strength and fibrinolysis. 
With results available within 20 min, TEG can measure 
the function of the entire coagulation cascade including 
platelets, hence simplifying the diagnosis of coagulopa-
thy and guiding further management [2, 19]. Its speed 
and ability to simultaneously measure multiple aspects of 
coagulation offer major advantages over standard labora-
tory methods. It can be used to guide appropriate use of 
rFVIIa, identify hypercoagulable states and can identify 
patients at risk for thrombotic events, even when these 
patients are receiving deep vein thrombosis prophylaxis 
and have therapeutic concentrations of anti factor Xa [20, 
32]. However, TEG is still not widely available and some 
reliance on traditional methods of assessing clotting func-
tion remains [11].
Rewarming
Though hypothermia is associated with poor outcome 
including mortality in multiple trauma patients, the ben-
efits of rewarming remain unclear. Laboratory work has 
suggested that permissive hypothermia may be beneficial 
in certain situations, but this has not been demonstrable in 
clinical practice and early rewarming is still advocated [41–
43]. Where hypothermia has not been prevented, it should 
therefore be reversed. Rewarming may increase vasodila-
tion of peripheral vascular beds, hence improving tissue 
perfusion, it is recommended that the torso is rewarmed 
before the extremities to prevent progressive hypotension 
as a result of this vasodilation. Rewarming can be carried 
out in the following ways:
1. Passive external rewarming—achieved by warm blan-
kets or increasing room temperature.
2. Active external rewarming—through the use of forced 
air-warming devices and other heaters.
3. Active internal core rewarming—warming admin-
istered fluids and potentially the use of heated oxy-
gen. Warmed bladder and peritoneal irrigation, arte-
riovenous rewarming and even haemodialysis have all 
been successfully used in extreme circumstances. Such 
extracorporeal rewarming techniques are the most effi-
cient, increasing body temperature at a rate of 4–5 °C 
per hour (compared to only 2 °C by the other afore-
mentioned techniques) [19].
No specific guidelines exist regarding techniques to 
employ in specific situations, it is important to take steps 
to prevent hypothermia worsening and identify such states 
when they occur. Where patients fail to respond to simple 
measures consideration should be given to more aggres-
sive techniques. When hypothermia is persistent or relaps-
ing, further investigations should be carried out to look for 
occult on-going haemorrhage [11, 44].
Correction of acidosis
The ultimate treatment to reverse metabolic acidosis in 
the severely injured is the restoration of organ perfusion 
through volume replacement, permitting acid-base balance 
to normalise by homeostatic mechanisms. This may be dif-
ficult to achieve until haemorrhage is controlled, indeed 
such measures provide good endpoints to guide resusci-
tation and persisting abnormalities of acid-base balance 
should prompt investigation for on-going occult bleeding 
and hypoperfusion. Whilst it is possible to correct acid-base 
disturbances pharmacologically, this has more relevance 
where the cause includes base losses such as in diabetic 
ketoacidosis. Administration of sodium bicarbonate has 
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been shown to cause the production of carbon dioxide, par-
adoxically lowering intra cellular pH and leading to a fall in 
the ionised calcium concentration which has implications 
for coagulation and cardiac function. Tris(hydroxymethyl)
aminomethane leads to a similar effect by accepting hydro-
gen ions and it’s use has been reported in trauma patients 
[23]. However, it is widely accepted that correction of met-
abolic acidosis in these patients is best achieved through 
aggressive blood and blood product administration along-
side appropriate use of vasopressors until the other compo-
nents of the lethal triad can be addressed [11]. No studies 
have shown any advantage to pharmacologic management 
of acidosis in the trauma setting and there are currently no 
specific guidelines to address the specific reversal of acido-
sis in the trauma patient [11].
Early haemorrhage control
Experience dealing with patients suffering from haemor-
rhagic shock has demonstrated it is often not possible to 
restore normal physiology until haemorrhage has been 
arrested. Indeed, until that point many patients continue to 
deteriorate despite resuscitative efforts [15]. The speed with 
which haemorrhage control is achieved is therefore critical. 
The focus of major trauma protocols on rapid delivery of 
patients to facilities that allow this are not misplaced [45, 
46].
Simple interventions that reduce bleeding before defini-
tive care is available should form part of trauma care 
resuscitative protocols. Examples of this include the use 
of pelvic binders, application of compressive dressings 
to actively bleeding wounds and the use of tourniquets in 
more severe injuries where this is not effective [47]. These 
measures should be taken as soon as possible, increas-
ingly in the pre-hospital setting. Tourniquets render the 
limb ischaemic and may lead to nerve injury, these should 
therefore be employed with caution. It is important that 
everything possible is done after application to deliver the 
patient expediently to appropriate definitive care facilitates. 
In cases of devastating limb injury, the arrest of life threat-
ening haemorrhage must outweigh any concerns about limb 
salvage [48]. Temporary aortic balloon catheter tamponade 
is seeing a resurgence in use [53]. This can be used as a 
temporising measure in patients with catastrophic abdomi-
nal, pelvic and lower limb haemorrhage. Whilst there are 
significant potential complications and consequences, when 
simple interventions fail or are not possible, this provides 
a valid alternative [1]. Many such interventions have been 
adapted from military practice and further developments 
are still being seen [49].
The use of tranexamic acid (TXA) in the major trauma 
setting has been found through multiple studies to reduce 
the mortality associated with blood loss when administered 
during resuscitation [27]. TXA functions by blocking the 
lysine-binding sites on plasminogen and hence inhibit-
ing fibrinolysis, resulting in inhibition of clot degradation 
[50]. The CRASH-2 trial, showed that the use of TXA 
could reduce mortality rates associated with exsanguinat-
ing haemorrhage by 15 % with few complications. To have 
such an effect it must be given within 3 h of injury as an 
immediate intravenous dose of one gram followed by a fur-
ther 1 g infusion over 8 h. It therefore should form part of 
early resuscitative protocols. The use of other pro-coagu-
lant therapies remains controversial. Early administration 
of rFVIIa has been associated with decreased red blood 
cell use in bleeding patients [32, 51]. Other research has 
shown a decrease in the transfusion requirements associ-
ated with its early use as an adjunct to massive transfu-
sion. However, clinical application remains debatable, 
with questions remaining regarding the appropriate timing 
of delivery, selection of patients and the simultaneous use 
of additional blood components to enhance its effect [32]. 
The drug appears to be less effective in acidotic patients but 
remains effective in all but the most severely hypothermic. 
Recent evidence has suggested an increased risk of subse-
quent thromboembolic complication following its use [9].
Surgical haemorrhage control is still regarded as the gold 
standard for the majority of patients and should be rapidly 
available where required. Open surgery comes with a cost 
in terms of physiologic derangement however and modern 
alternatives are increasingly being employed. Endovascular 
management by interventional radiology allows selective 
embolisation of bleeding vessels and organs and stent graft-
ing of major and peripheral vessel injuries without many 
of the specific risks of open procedures [52]. It is often 
definitive in nature. Temporary intravascular shunts can 
be life and limb saving by bridging damaged vessels and 
maintaining blood flow, hence reducing acute haemorrhage 
and critical warm ischaemia times of distal organs and 
limbs [1]. As timing of interventions is so critical, inter-
ventional radiology facilitates need to be rapidly available 
24 h a day to be effective and, this requires organisational 
development and investment in major trauma centres [54]. 
It is important to balance decision making and remember 
that not all bleeding can be controlled non-operatively in a 
timely manner [55]. Multidisciplinary input is critical and 
the application of some of these techniques remains contro-
versial [24, 56].
Conclusions
Understanding of trauma resuscitation has greatly improved 
in recent years and continues to develop. It is important that 
the concepts and practicalities of damage control resus-
citation are understood by all those involved in the early 
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management of trauma patients and early recognition of 
those who might benefit from a damage control approach 
is critical. Given that interventions are so time dependent, 
it is likely that by developing trauma systems and proto-
cols, further improvements in outcome can be achieved. 
Research work in this area will allow these approaches to 
be targetted more accurately to those patients who can ben-
efit most.
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